Document is current
Any future updates will be listed below
-
Authors
Salis, Zubeyir https://orcid.org/0000-0003-2982-4591
Gallego, Blanca
Sainsbury, Amanda https://orcid.org/0000-0001-9176-1574
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council of Australia (1135897)
- License Information
-
More Information
Article History
Received: 4 January 2023
Accepted: 18 April 2023
First Online: 26 April 2023
Declarations
:
: We used data from the Osteoarthritis Initiative (OAI) study. OAI data is openly available to researchers for scientific and educational purposes. The local institutional review boards of the OAI study centers obtained informed consent from all subjects and/or their legal guardian(s). The local institutional review boards of the OAI study centers reviewed and approved the ethics approval and any experimental protocols. The methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: ZS and AS own 50% of each of the shares in Zuman International Pty Ltd, which receives royalties and other payments for educational resources and services in adult weight management and research methodology. AS additionally reports receiving presentation fees and travel reimbursements from Eli Lilly and Co, the Pharmacy Guild of Australia, Novo Nordisk, the Dietitians Association of Australia, Shoalhaven Family Medical Centres, the Pharmaceutical Society of Australia, and Metagenics, and serving on the Nestlé Health Science Optifast VLCD advisory board from 2016 to 2018. BG has no competing interest.
